Beacon Pointe Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$1.04M Buy
11,727
+59
+0.5% +$4.9K 0.19% 102
2019
Q3
$882K Sell
11,668
-4,105
-26% -$281K 0.19% 107
2019
Q2
$1.15M Sell
15,773
-400
-2% -$31.4K 0.24% 88
2019
Q1
$1.3M Buy
16,173
+266
+2% +$21.8K 0.3% 71
2018
Q4
$1.47M Buy
+15,907
New +$1.4M 0.53% 43

Other funds holding ABBV

Beacon Pointe Wealth Advisors's ABBV Position: Q4 2019 in Review

Beacon Pointe Wealth Advisors increased its AbbVie (ABBV) stake by 0.51% in Q4 2019, buying an estimated $4.9K and bringing the position to 11,727 shares worth $1.04M. The position accounts for 0.19% of the portfolio, ranked #102.

Beacon Pointe Wealth Advisors first reported a position in ABBV in Q4 2018 and has held it in 5 quarters since. The position peaked at $1.47M in Q4 2018. 2,243 funds tracked by Wall St. Rank hold ABBV as of Q4 2019.

  • Beacon Pointe Wealth Advisors held 11,727 shares of AbbVie worth $1.04M as of Q4 2019.
  • Beacon Pointe Wealth Advisors bought 59 AbbVie shares in Q4 2019, an estimated $4.9K.
  • AbbVie made up 0.19% of Beacon Pointe Wealth Advisors's portfolio in Q4 2019, its #102 holding.
  • Beacon Pointe Wealth Advisors first reported a position in AbbVie in Q4 2018 and has held it in 5 quarters since.
  • Beacon Pointe Wealth Advisors's AbbVie position peaked at $1.47M in Q4 2018.
  • 2,243 funds tracked by Wall St. Rank held AbbVie as of Q4 2019.

Based on Beacon Pointe Wealth Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.